Genetic Technologies

Editorial in @JAMAOnsuggests #breastcancer risk assessment should be conducted yearly, should start earlier & consider factors such as family history + breast density. Read more: jamanetwork.com/journals/jamao…

Most women diagnosed with breast cancer will have no family history of the disease. But what if we told you that you could find out your personal risk of #breastcancer with a simple saliva test? #KnowYourRisk with geneType, now available at Genomic Health: genomichealth.com.au

The final in our 4-part series on predictive factors contributing to #breastcancer, catching up with Dr. Erika Spaeth, Director of Clinical and Scientific Affairs at Genetic Technologies & Will Mountford discuss #riskassessment in clinical practice. researchpod.org/health-medicin…

⚠️ Do you know if you're at risk of serious disease? #geneType testing is now available at Genomic Health Clinic, a comprehensive private genetic service based in Perth, WA and servicing the whole of Australia via telehealth. Book in for a consultation 👉 genomichealth.com.au

Learn why Dr. Ora Gordon, Regional Medical Director of the Center for Clinical Genetics & Genomics for Providence Southern California, feels confident in the recommendations she makes for her breast cancer patients based on the geneType test: genetype.com/for-clinical-p…

If your patients have a family history of #breastcancer but don’t test + for a pathogenic variant, where do they sit on the spectrum of increased risk? Learn more: genetype.com/for-clinical-p… #geneType #bcsm #meded #knowyourrisk #FOAMed

The risk of developing breast cancer comes from many things: family history, age, & polygenic factors to calculate a single risk score, affecting screening & risk reduction actions. This summer, dive deeper into explaining risk scores to your patients: genetype.com/for-clinical-p…

Cel S. is a patient who took action after getting her geneType test results. Learn more about #breastcancer risk assessment that incorporates clinical risk factors + polygenic risk factors to assess absolute risk for women in the general population: genetype.com/for-clinical-p…

#GENE is starting testing operations in the United States for #geneType™ genetic risk assessments at Gene by Gene, a premier specialty genetic laboratory based in Houston, Texas. Read more 👇 globenewswire.com/news-release/2… #GeneticTechnologies #GTG #genomics #precisionmedicine

More on predictive factors contributing to #breastcancer, catching up w/ Dr. Erika Spaeth, Director of Clinical and Scientific Affairs at Genetic Technologies & Will Mountford from @ResearchpodHQ about embedding #riskassessment in healthcare systems: researchpod.org/health-medicin…

Statistics using population-based data compiled by @AmericanCancer show in all cancer deaths, colorectal cancer is the leading cause for men aged 30-40. Learn more about making comprehensive risk assessment part of your practice: genetype.com/for-medical-pr…

The Prevention and Early Detection of Cancer Network (PREDICT) Symposium 2024 is happening this Friday, 14 June in Melbourne. #geneType is proudly sponsoring the Symposium this year alongside @NBCFAus. More: vcccalliance.org.au/news-and-event… @VCCCAlliance @Cancer_Research #cancerprevention

June 2 is National Cancer Survivors Day. In addition to celebrating survivors and their families, it's a good day to listen to their stories of how early detection and intervention can save lives. genetype.com/for-clinical-p… #bcsm #cancersurvivors #KnowYourRisk

May is #StrokeAwareness Month. Learn more about geneType’s personalized genetic risk assessment for improved early detection of cardiovascular conditions like coronary artery disease or atrial fibrillation, and learn more about tailored healthcare plans: genetype.com/for-clinical-p…

Study from @AmericanCancer finds alarming trend: Among all cancer deaths in women, #breastcancer is now the leading cause in their 30s and 40s, using population-based data. Learn more about making comprehensive #riskassessment part of your practice: genetype.com/for-clinical-p…

May is #SkinCancer Awareness Month. Encourage your patients to develop lifelong habits of sun exposure protection, skin self-exams and the benefits of early detection and risk assessment. Learn more: genetype.com/for-clinical-p… #KnowYourRisk

Happy #WomensHealthWeek! Encourage your patients to prioritize their health & make screening appointments for #BreastCancer. Beyond family history, risk assessment can determine screening, risk-reducing medication & lifestyle interventions. Learn more: genetype.com/for-clinical-p…

Study in @JCO_ASCO summarizing progress toward risk-tailored general pop screening for breast cancer finds polygenic risk scores correlated with positive predictive value, suggesting clinical utility. Read here: ascopubs.org/doi/10.1200/JC… #KnowYourRisk #bcsm

#GTG #GENE is pleased to announce a strategic joint sales & marketing agreement with US based @WellworksForYou, to incorporate the #geneType portfolio of tests into Wellworks' fully flexible, scalable employee wellness solutions across the US Read more: bit.ly/3y7EdAi

Happy Nurse Appreciation Week! Thank you to all the nurses who work tirelessly every day to make cancer screening and risk assessment understandable and accessible. #NursesMaketheDifference #ThankANurse #NationalNursesWeek